🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-04-09
Trial ID
NCT00652938
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and the safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-21
Trial ID
NCT01462357
This extension study is conducted to assess the efficacy of the GSK 580299 ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06
Trial ID
NCT00929526
Treatments Being Tested
This extension study is designed to assess the safety of GSK Biological's H...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-01-24
Trial ID
NCT01249365
Treatments Being Tested
Cervical cancer is the second most common cancer among women worldwide. App...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-01
Trial ID
NCT00481767
Treatments Being Tested
This phase IV trial investigates whether one dose of a human papillomavirus...
Status
Active Not Recruiting
Location
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Start Date
2017-11-29
Trial ID
NCT03180034
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-12
Trial ID
NCT00552279
Treatments Being Tested
This phase IV trial tests whether a single dose of the human papillomavirus...
Status
Active Not Recruiting
Location
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Start Date
2022-03-01
Trial ID
NCT05237947
The purpose of this study is to evaluate the immunogenicity and safety of t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02082639
This phase 3b study is designed to assess the safety of GlaxoSmithKline Bio...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01-01
Trial ID
NCT00799825
Treatments Being Tested